Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 4772
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM

The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice

Hussain Nazimul, Ghanekar Yashoda, Kaur Inderjeet

Year : 2007| Volume: 55| Issue : 6 | Page no: 445-450

   This article has been cited by
 
1 A review of anti-VEGF agents for proliferative diabetic retinopathy
P Osaadon,X J Fagan,T Lifshitz,J Levy
Eye. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Microvascular complications and diabetic retinopathy: recent advances and future implications
Megha Barot,Mitan R Gokulgandhi,Sulabh Patel,Ashim K Mitra
Future Medicinal Chemistry. 2013; 5(3): 301
[Pubmed]  [Google Scholar] [DOI]
3 The pathogenesis of early retinal changes of diabetic retinopathy
G. B. Arden, S. Sivaprasad
Documenta Ophthalmologica. 2012;
[HTML Full text]  [Google Scholar] [DOI]
4 Treatment of proliferative diabetic retinopathy with anti-VEGF agents
Aysha Salam, Raeba Mathew, Sobha Sivaprasad
Acta Ophthalmologica. 2011; : no
[HTML Full text]  [Google Scholar] [DOI]
5 Review of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy
Jardeleza, M.S.R. and Miller, J.W.
. 2009; 24(2): 87-92
[Pubmed]  [Google Scholar]
6 Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study
Raquel Costa, Ângela Carneiro, Ana Rocha, Ana Pirraco, Manuel Falcão, Luísa Vasques, Raquel Soares
Journal of Cellular Biochemistry. 2009; 108(6): 1410-1417
[Pubmed]  [Google Scholar] [DOI]
7 Effects of hydralazine on ocular blood flow and laser-induced choroidal neovascularization
Jiang, W., Chiou, G.C.Y.
International Journal of Ophthalmology. 2008; 8(12): 2359-2363
[Pubmed]  [Google Scholar]
8 New VEGF antagonists as possible therapeutic agents in vascular disease
Slevin, M., Kumar, P., Wang, Q., Kumar, S., Gaffney, J., Grau-Olivares, M., Krupinski, J.
Expert Opinion on Investigational Drugs. 2008; 17(9): 1301-1314
[Pubmed]  [Google Scholar]
9 New VEGF antagonists as possible therapeutic agents in vascular disease
M Slevin,P Kumar,Quiyu Wang,S Kumar,J Gaffney,M Grau-Olivares,J Krupinski
Expert Opinion on Investigational Drugs. 2008; 17(9): 1301
[Pubmed]  [Google Scholar] [DOI]

 

Read this article